454, SoftGenetics Enter Co-Promotion Deal in Next-Gen Sequencing Informatics
454 users will be able to leverage SoftGenetics’ NextGENe software.!--h2>
454 Life Sciences and SoftGenetics inked an agreement centered on informatics solutions for sequencing. Under the co-promotion arrangement, users of 454 sequencing systems will have access to data-analysis options provided by SoftGenetics’ NextGENe® software.
NextGENe is a free-standing solution that is compatible with 454 next-generation sequencing (NGS) data. The companies say that it can be leveraged across a variety of applications including targeted amplicon resequencing, exome sequencing, transcriptome sequencing, forensic profiling, and more. The software package also reportedly provides an extensive GS Data Analysis Software suite.
“This agreement permits both 454 and SoftGenetics the opportunity to more fully understand and address the rapidly changing needs of the NGS marketplace,” states SoftGenetics co-founder John Fosnacht. “SoftGenetics welcomes the opportunity to work closely with our colleagues at 454 Life Sciences to provide our mutual customers with integrated sequencing and analysis systems that not only deliver the required quality and sensitivity but also the efficiency needed in today’s scientific and economic environments.”
SoftGenetics offers 30-day trials and no-cost, web-based training on its genetic analysis software packages. The company has similar NextGENe arrangements with Life Technologies and Ambry Genetics. Last April SoftGenetics entered into a reseller’s agreement with Life Tech, which will offer the NextGENe software to process sequencing data from the Ion Personal Genome Machine. In December 2009, Ambry partnered with SoftGenetics so that it could also use the NextGENe solution in its NGS projects.